MARAGANORE JOHN
Insider CIK 1180432 · ALNY Chief Executive Officer, Director · BLUE Director · TAK Director · AGIO Director · RGLS Director, 10% owner · BEAM Director · KYMR Director · PROK Director · RAPP Director · COAG Director · CTY Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RAPP Rapport Therapeutics, Inc. | P Buy | 2026-10-22 | 2026-10-22 | 1,172 | $26.92 | $31.5K | 9,411 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | P Buy | 2026-10-22 | 2026-10-22 | 8,239 | $26.38 | $217.3K | 8,239 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion deriv | 2026-10-19 | 2026-10-19 | 56,095 | — | $0 | 0 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion deriv | 2026-10-19 | 2026-10-19 | 500,000 | — | $0 | 0 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion | 2026-10-19 | 2026-10-19 | 610,759 | — | — | 1,470,692 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | A Award deriv | 2026-10-15 | 2026-10-19 | 22,649 | — | $0 | 22,649 | SEC↗ |
| TAK TAKEDA PHARMACEUTICAL CO L | D To issuer deriv | 2026-07-10 | 2026-07-06 | 1,152 | $4931.20 | $5.68M | 0 | SEC↗ |
| TAK TAKEDA PHARMACEUTICAL CO L | A Award deriv | 2026-07-01 | 2026-07-06 | 1,319 | — | $0 | 1,319 | SEC↗ |
| TAK TAKEDA PHARMACEUTICAL CO L | A Award | 2026-07-01 | 2026-07-06 | 3,800 | — | $0 | 10,400 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2026-06-24 | 2026-06-25 | 6,068 | — | $0 | 6,068 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | A Award deriv | 2026-06-10 | 2026-06-10 | 15,200 | — | $0 | 15,200 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2026-06-03 | 2026-06-05 | 19,676 | — | $0 | 19,676 | SEC↗ |
| COAG Hemab Therapeutics Holding | C Conversion deriv | 2026-05-04 | 2026-05-04 | 817 | — | $0 | 0 | SEC↗ |
| COAG Hemab Therapeutics Holding | C Conversion deriv | 2026-05-04 | 2026-05-04 | 817 | — | $0 | 0 | SEC↗ |
| COAG Hemab Therapeutics Holding | C Conversion | 2026-05-04 | 2026-05-04 | 17,974 | — | $0 | 17,974 | SEC↗ |
| COAG Hemab Therapeutics Holding | C Conversion | 2026-05-04 | 2026-05-04 | 17,974 | — | $0 | 35,948 | SEC↗ |
| COAG Hemab Therapeutics Holding | A Award deriv | 2026-01-29 | 2026-05-04 | 107,338 | — | $0 | 107,338 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2025-06-25 | 2025-06-26 | 16,000 | — | $0 | 16,000 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | A Award deriv | 2025-06-17 | 2025-06-18 | 21,850 | — | $0 | 21,850 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2025-06-04 | 2025-06-06 | 33,662 | — | $0 | 33,662 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2024-06-18 | 2024-06-20 | 16,000 | — | $0 | 16,000 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 23,114 | — | $0 | 23,114 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2023-06-29 | 2023-07-03 | 48,128 | — | $0 | 48,128 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2023-06-15 | 2023-06-20 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 16,532 | — | $0 | 16,532 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2022-09-01 | 2022-09-02 | 10,391 | — | $0 | 10,391 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2022-07-11 | 2022-07-13 | 614,013 | — | $0 | 614,013 | SEC↗ |
| PROK PROKIDNEY CORP. | A Award deriv | 2022-07-11 | 2022-07-13 | 614,013 | — | $0 | 614,013 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2022-06-21 | 2022-06-23 | 4,975 | — | $0 | 4,975 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2022-06-21 | 2022-06-23 | 29,307 | — | $0 | 29,307 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2022-05-20 | 2022-05-24 | 1,585 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2022-05-20 | 2022-05-24 | 1,585 | — | $0 | 30,028 | SEC↗ |
| KYMR Kymera Therapeutics, Inc. | A Award deriv | 2022-01-18 | 2022-01-19 | 24,000 | — | $0 | 24,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-12-22 | 2021-12-23 | 2 | $190.50 | $381 | 227,982 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-12-22 | 2021-12-23 | 319 | $186.02 | $59.3K | 227,663 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-12-22 | 2021-12-23 | 6,315 | $189.13 | $1.19M | 227,984 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2021-12-21 | 2021-12-23 | 14,167 | — | $0 | 234,299 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-12-10 | 2021-12-14 | 1,036 | — | $0 | 73,964 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-12-10 | 2021-12-14 | 1,124 | — | $0 | 63,876 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-12-10 | 2021-12-14 | 839 | — | $0 | 51,661 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-12-10 | 2021-12-14 | 2,368 | — | $0 | 22,632 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-12-10 | 2021-12-14 | 2,368 | $42.22 | $100.0K | 220,132 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-12-10 | 2021-12-14 | 1,036 | $96.45 | $99.9K | 215,801 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-12-10 | 2021-12-14 | 1,124 | $88.95 | $100.0K | 216,925 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-12-10 | 2021-12-14 | 839 | $119.13 | $100.0K | 217,764 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-11-12 | 2021-11-12 | 33,978 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-11-12 | 2021-11-12 | 33,978 | $7.10 | $241.2K | 248,743 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-11-12 | 2021-11-12 | 670 | $174.34 | $116.8K | 214,765 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-11-12 | 2021-11-12 | 683 | $173.25 | $118.3K | 215,435 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-11-12 | 2021-11-12 | 14,518 | $172.22 | $2.50M | 216,118 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-11-12 | 2021-11-12 | 7,742 | $171.35 | $1.33M | 230,636 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-11-12 | 2021-11-12 | 10,365 | $170.36 | $1.77M | 238,378 | SEC↗ |
| BEAM Beam Therapeutics Inc. | A Award deriv | 2021-11-05 | 2021-11-08 | 13,133 | — | $0 | 13,133 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-08-13 | 2021-08-16 | 33,979 | — | $0 | 33,978 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-08-13 | 2021-08-16 | 23,336 | $199.92 | $4.67M | 218,807 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-08-13 | 2021-08-16 | 33,979 | $7.10 | $241.3K | 248,744 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-08-13 | 2021-08-16 | 214 | $201.55 | $43.1K | 214,765 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-08-13 | 2021-08-16 | 3,828 | $200.84 | $768.8K | 214,979 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-08-13 | 2021-08-16 | 4,160 | $198.93 | $827.5K | 242,143 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-08-13 | 2021-08-16 | 2,441 | $198.02 | $483.4K | 246,303 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2021-05-28 | 2021-06-02 | 1,686 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2021-05-28 | 2021-06-02 | 1,686 | — | $0 | 28,443 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2021-05-20 | 2021-05-24 | 8,888 | — | $0 | 8,888 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2021-05-20 | 2021-05-24 | 1,585 | — | $0 | 1,585 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-05-13 | 2021-05-17 | 33,979 | — | $0 | 67,957 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-05-13 | 2021-05-17 | 33,979 | $7.10 | $241.3K | 248,744 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-05-13 | 2021-05-17 | 4,512 | $129.32 | $583.5K | 241,217 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-05-13 | 2021-05-17 | 9,121 | $130.34 | $1.19M | 232,096 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-05-13 | 2021-05-17 | 11,203 | $131.18 | $1.47M | 220,893 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-05-13 | 2021-05-17 | 3,481 | $132.32 | $460.6K | 217,412 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-05-13 | 2021-05-17 | 1,624 | $133.56 | $216.9K | 215,788 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-05-13 | 2021-05-17 | 1,023 | $134.37 | $137.5K | 214,765 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-05-13 | 2021-05-17 | 3,015 | $128.30 | $386.8K | 245,729 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-04-20 | 2021-04-21 | 270 | $134.62 | $36.3K | 214,765 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-04-20 | 2021-04-21 | 7,237 | $131.75 | $953.5K | 215,035 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2021-04-19 | 2021-04-21 | 16,236 | — | $0 | 222,272 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2021-02-25 | 2021-02-26 | 33,979 | — | $0 | 101,936 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2021-02-25 | 2021-02-26 | 33,979 | $7.10 | $241.3K | 240,015 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-02-25 | 2021-02-26 | 1,001 | $143.88 | $144.0K | 239,014 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-02-25 | 2021-02-26 | 6,129 | $145.15 | $889.6K | 232,885 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-02-25 | 2021-02-26 | 9,376 | $146.13 | $1.37M | 223,509 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-02-25 | 2021-02-26 | 6,097 | $146.98 | $896.1K | 217,412 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-02-25 | 2021-02-26 | 599 | $154.59 | $92.6K | 206,036 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-02-25 | 2021-02-26 | 431 | $153.33 | $66.1K | 206,635 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-02-25 | 2021-02-26 | 1,138 | $152.46 | $173.5K | 207,066 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-02-25 | 2021-02-26 | 1,415 | $151.31 | $214.1K | 208,204 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-02-25 | 2021-02-26 | 2,054 | $150.22 | $308.6K | 209,619 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-02-25 | 2021-02-26 | 1,364 | $148.96 | $203.2K | 211,673 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2021-02-25 | 2021-02-26 | 4,375 | $148.00 | $647.5K | 213,037 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-02-24 | 2021-02-26 | 79,998 | — | $0 | 79,998 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-02-12 | 2021-02-16 | 5,412 | $156.00 | $844.3K | 206,343 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2021-02-12 | 2021-02-16 | 307 | $151.94 | $46.6K | 206,036 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2021-02-11 | 2021-02-16 | 17,504 | — | $0 | 52,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2021-02-11 | 2021-02-16 | 14,166 | — | $0 | 211,755 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | G Gift | 2021-02-04 | 2021-06-02 | 3,415 | — | $0 | 26,757 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-11-19 | 2020-11-20 | 34,765 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-11-19 | 2020-11-20 | 102 | $126.62 | $12.9K | 197,589 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-11-19 | 2020-11-20 | 10,187 | $125.35 | $1.28M | 197,691 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-11-19 | 2020-11-20 | 5,489 | $124.49 | $683.3K | 207,878 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-11-19 | 2020-11-20 | 18,987 | $123.55 | $2.35M | 213,367 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-11-19 | 2020-11-20 | 34,765 | $9.14 | $317.8K | 232,354 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-08-20 | 2020-08-21 | 34,765 | — | $0 | 34,765 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-08-20 | 2020-08-21 | 34,765 | $9.14 | $317.8K | 232,354 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-08-20 | 2020-08-21 | 4,775 | $135.09 | $645.1K | 227,579 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-08-20 | 2020-08-21 | 21,448 | $136.07 | $2.92M | 206,131 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-08-20 | 2020-08-21 | 8,542 | $136.86 | $1.17M | 197,589 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2020-05-29 | 2020-06-01 | 1,878 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2020-05-29 | 2020-06-01 | 1,878 | — | $0 | 30,172 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2020-05-28 | 2020-06-01 | 1,686 | — | $0 | 1,686 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2020-05-28 | 2020-06-01 | 8,096 | — | $0 | 8,096 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-05-20 | 2020-05-22 | 34,765 | — | $0 | 69,530 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-05-20 | 2020-05-22 | 13,437 | $142.51 | $1.91M | 218,917 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-05-20 | 2020-05-22 | 34,765 | $9.14 | $317.8K | 232,354 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-05-20 | 2020-05-22 | 16,315 | $143.46 | $2.34M | 202,602 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-05-20 | 2020-05-22 | 5,013 | $144.33 | $723.5K | 197,589 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2020-04-07 | 2020-04-09 | 14,167 | — | $0 | 204,160 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2020-04-07 | 2020-04-09 | 256 | $106.27 | $27.2K | 197,589 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2020-04-07 | 2020-04-09 | 6,315 | $104.75 | $661.5K | 197,845 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2020-02-26 | 2020-02-28 | 88,240 | — | $0 | 88,240 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2020-02-20 | 2020-02-21 | 34,765 | — | $0 | 104,295 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-02-20 | 2020-02-21 | 2,672 | $128.62 | $343.7K | 222,086 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-02-20 | 2020-02-21 | 502 | $133.42 | $67.0K | 189,993 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-02-20 | 2020-02-21 | 1,586 | $129.33 | $205.1K | 220,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-02-20 | 2020-02-21 | 5,053 | $131.07 | $662.3K | 215,447 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-02-20 | 2020-02-21 | 6,887 | $131.61 | $906.4K | 208,560 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2020-02-20 | 2020-02-21 | 18,065 | $132.81 | $2.40M | 190,495 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2020-02-20 | 2020-02-21 | 34,765 | $9.14 | $317.8K | 224,758 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | G Gift | 2020-02-14 | 2020-02-28 | 2,400 | — | $0 | 30,209 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | G Gift | 2020-02-14 | 2020-02-28 | 1,915 | — | $0 | 28,294 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-12-23 | 2019-12-26 | 17,498 | — | $0 | 34,996 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-11-22 | 2019-11-26 | 17,498 | — | $0 | 17,498 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2019-10-14 | 2019-10-16 | 49,456 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2019-10-14 | 2019-10-16 | 26,754 | $79.80 | $2.13M | 191,863 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2019-10-14 | 2019-10-16 | 20,832 | $78.92 | $1.64M | 218,617 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2019-10-14 | 2019-10-16 | 49,456 | $16.43 | $812.6K | 239,449 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2019-10-14 | 2019-10-16 | 1,870 | $80.31 | $150.2K | 189,993 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-08-06 | 2019-08-07 | 16,250 | — | $0 | 65,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-08-06 | 2019-08-07 | 6,250 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2019-07-11 | 2019-08-07 | 34 | — | $0 | 3,133 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | G Gift | 2019-06-12 | 2019-06-14 | 5,000 | — | $0 | 32,609 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-06-05 | 2019-06-07 | 6,250 | — | $0 | 18,750 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise deriv | 2019-05-31 | 2019-05-31 | 1,400 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | M Exercise | 2019-05-31 | 2019-05-31 | 1,400 | — | $0 | 37,609 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2019-05-29 | 2019-05-31 | 1,878 | — | $0 | 1,878 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2019-05-29 | 2019-05-31 | 8,919 | — | $0 | 8,919 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2019-05-15 | 2019-05-17 | 49,457 | — | $0 | 49,456 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2019-05-15 | 2019-05-17 | 49,457 | $16.43 | $812.6K | 239,450 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2019-05-15 | 2019-05-17 | 49,457 | $70.00 | $3.46M | 189,993 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2019-04-09 | 2019-05-17 | 61 | — | $0 | 3,099 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2019-02-28 | 2019-03-01 | 85,000 | — | $0 | 85,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-11-21 | 2018-11-26 | 98,636 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-11-21 | 2018-11-26 | 98,636 | $21.35 | $2.11M | 249,933 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2018-11-21 | 2018-11-26 | 59,940 | $72.68 | $4.36M | 189,993 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-10-18 | 2018-11-26 | 17 | — | $0 | 3,038 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-09-27 | 2018-09-28 | 6,250 | — | $0 | 12,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-09-27 | 2018-09-28 | 16,250 | — | $0 | 48,750 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-09-12 | 2018-11-06 | 0 | — | $0 | 36,209 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-09-12 | 2018-09-13 | 14,162 | $71.74 | $1.02M | 22,047 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-09-11 | 2018-09-13 | 11,155 | $72.52 | $809.0K | 38,609 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | S Sale | 2018-09-11 | 2018-09-13 | 2,400 | $73.82 | $177.2K | 36,209 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-08-21 | 2018-08-23 | 16,250 | — | $0 | 32,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-08-10 | 2018-08-14 | 25,000 | — | $0 | 75,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-08-10 | 2018-08-14 | 25,000 | — | $0 | 75,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-07-25 | 2018-07-27 | 50,000 | — | $0 | 98,636 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-07-25 | 2018-07-27 | 50,000 | $21.35 | $1.07M | 201,297 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-07-25 | 2018-07-27 | 3,847 | $103.69 | $398.9K | 195,450 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-07-25 | 2018-07-27 | 1,400 | $106.25 | $148.8K | 151,297 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-07-25 | 2018-07-27 | 34,995 | $105.83 | $3.70M | 152,697 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-07-25 | 2018-07-27 | 7,758 | $104.83 | $813.3K | 187,692 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-07-25 | 2018-07-27 | 2,000 | $102.51 | $205.0K | 199,297 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-07-10 | 2018-07-27 | 31 | — | $0 | 3,021 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-05-31 | 2018-06-04 | 1,400 | — | $0 | 1,400 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2018-05-31 | 2018-06-04 | 5,700 | — | $0 | 5,700 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-04-16 | 2018-07-27 | 30 | — | $0 | 2,990 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-03-01 | 2018-03-05 | 52,500 | — | $0 | 52,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-12-20 | 2017-12-21 | 6,250 | — | $0 | 6,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-12-19 | 2017-12-21 | 1,587 | — | $0 | 148,413 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-12-19 | 2017-12-21 | 1,587 | $63.00 | $100.0K | 151,297 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-11-22 | 2017-11-24 | 73,415 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-11-22 | 2017-11-24 | 25,263 | $129.97 | $3.28M | 197,862 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-11-22 | 2017-11-24 | 73,415 | $31.39 | $2.30M | 223,125 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-11-22 | 2017-11-24 | 25,036 | $130.88 | $3.28M | 172,826 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-11-22 | 2017-11-24 | 20,433 | $131.82 | $2.69M | 152,393 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-11-22 | 2017-11-24 | 2,683 | $132.73 | $356.1K | 149,710 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-11-15 | 2017-11-17 | 74,000 | — | $0 | 73,415 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-11-15 | 2017-11-17 | 600 | $130.22 | $78.1K | 149,710 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-11-15 | 2017-11-17 | 4,850 | $129.57 | $628.4K | 150,310 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-11-15 | 2017-11-17 | 10,571 | $128.48 | $1.36M | 155,160 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-11-15 | 2017-11-17 | 7,120 | $127.54 | $908.1K | 165,731 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-11-15 | 2017-11-17 | 28,399 | $126.60 | $3.60M | 172,851 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-11-15 | 2017-11-17 | 22,460 | $125.54 | $2.82M | 201,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-11-15 | 2017-11-17 | 74,000 | $31.39 | $2.32M | 223,710 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-11-06 | 2017-11-08 | 16,250 | — | $0 | 16,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-09-20 | 2017-09-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| BLUE bluebird bio, Inc. | M Exercise deriv | 2017-09-14 | 2017-09-18 | 18,868 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2017-09-14 | 2017-09-18 | 18,268 | $131.19 | $2.40M | 6,443 | SEC↗ |
| BLUE bluebird bio, Inc. | M Exercise | 2017-09-14 | 2017-09-18 | 18,868 | $2.09 | $39.4K | 24,711 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2017-09-14 | 2017-09-18 | 600 | $131.82 | $79.1K | 5,843 | SEC↗ |
| BLUE bluebird bio, Inc. | M Exercise deriv | 2017-08-24 | 2017-08-28 | 13,839 | — | $0 | 18,868 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2017-08-24 | 2017-08-28 | 4,700 | $95.13 | $447.1K | 14,982 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2017-08-24 | 2017-08-28 | 6,385 | $96.32 | $615.0K | 8,597 | SEC↗ |
| BLUE bluebird bio, Inc. | M Exercise | 2017-08-24 | 2017-08-28 | 13,839 | $2.09 | $28.9K | 19,682 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2017-08-02 | 2017-08-28 | 2,754 | $96.74 | $266.4K | 5,843 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-07-07 | 2017-07-11 | 25,000 | — | $0 | 50,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2017-06-13 | 2017-06-15 | 8,000 | — | $0 | 8,000 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award deriv | 2017-06-08 | 2017-06-12 | 4,000 | — | $0 | 4,000 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award | 2017-06-08 | 2017-06-12 | 1,000 | — | $0 | 5,843 | SEC↗ |
| BLUE bluebird bio, Inc. | M Exercise deriv | 2017-03-03 | 2017-03-06 | 12,917 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | M Exercise deriv | 2017-03-03 | 2017-03-06 | 922 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | M Exercise | 2017-03-03 | 2017-03-06 | 12,917 | $5.50 | $71.0K | 18,682 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2017-03-03 | 2017-03-06 | 13,839 | $85.02 | $1.18M | 4,843 | SEC↗ |
| BLUE bluebird bio, Inc. | M Exercise | 2017-03-03 | 2017-03-06 | 922 | $0.95 | $876 | 5,765 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-01-05 | 2017-01-06 | 1,340 | — | $0 | 144,641 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-01-05 | 2017-01-06 | 1,340 | $18.66 | $25.0K | 149,710 | SEC↗ |
| BLUE bluebird bio, Inc. | G Gift | 2016-12-20 | 2017-01-23 | 1,450 | — | $0 | 4,843 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-12-20 | 2016-12-22 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-12-12 | 2016-12-14 | 30,151 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-12-12 | 2016-12-14 | 30,151 | $22.75 | $685.9K | 171,080 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2016-12-12 | 2016-12-14 | 22,710 | $42.61 | $967.7K | 148,370 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-10-12 | 2016-10-14 | 3,521 | — | $0 | 135,915 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-10-12 | 2016-10-14 | 4,019 | — | $0 | 145,981 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-10-12 | 2016-10-14 | 3,521 | $7.10 | $25.0K | 136,910 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-10-12 | 2016-10-14 | 4,019 | $18.66 | $75.0K | 140,929 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-07-20 | 2016-07-21 | 15,075 | — | $0 | 30,151 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-07-20 | 2016-07-21 | 2,418 | $66.00 | $159.6K | 133,389 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-07-20 | 2016-07-21 | 15,075 | $22.75 | $343.0K | 148,464 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-07-20 | 2016-07-21 | 600 | $64.29 | $38.6K | 147,864 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-07-20 | 2016-07-21 | 12,057 | $65.56 | $790.5K | 135,807 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-07-19 | 2016-07-21 | 15,076 | — | $0 | 45,226 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-07-19 | 2016-07-21 | 15,076 | $22.75 | $343.0K | 148,465 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-07-19 | 2016-07-21 | 13,571 | $63.73 | $864.9K | 134,894 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-07-19 | 2016-07-21 | 1,505 | $64.56 | $97.2K | 133,389 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2016-06-21 | 2016-06-23 | 8,000 | — | $0 | 41,125 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award deriv | 2016-06-02 | 2016-06-03 | 4,000 | — | $0 | 4,000 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award | 2016-06-02 | 2016-06-03 | 1,000 | — | $0 | 1,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-04-20 | 2016-04-21 | 15,075 | — | $0 | 60,302 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-04-20 | 2016-04-21 | 15,075 | $22.75 | $343.0K | 148,464 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-04-20 | 2016-04-21 | 12,670 | $67.38 | $853.7K | 135,794 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-04-20 | 2016-04-21 | 2,405 | $68.24 | $164.1K | 133,389 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-04-19 | 2016-04-21 | 15,076 | — | $0 | 75,377 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-04-19 | 2016-04-21 | 300 | $68.71 | $20.6K | 133,389 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-04-19 | 2016-04-21 | 9,371 | $67.02 | $628.0K | 139,094 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-04-19 | 2016-04-21 | 15,076 | $22.75 | $343.0K | 148,465 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-04-19 | 2016-04-21 | 5,405 | $68.00 | $367.5K | 133,689 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-02-01 | 2016-02-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-01-20 | 2016-01-21 | 15,076 | — | $0 | 90,453 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-20 | 2016-01-21 | 930 | $70.43 | $65.5K | 137,115 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-20 | 2016-01-21 | 1,200 | $66.28 | $79.5K | 147,265 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-01-20 | 2016-01-21 | 15,076 | $22.75 | $343.0K | 148,465 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-20 | 2016-01-21 | 325 | $74.61 | $24.2K | 133,389 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-20 | 2016-01-21 | 1,865 | $73.77 | $137.6K | 133,714 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-20 | 2016-01-21 | 400 | $72.51 | $29.0K | 135,579 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-20 | 2016-01-21 | 1,136 | $71.79 | $81.6K | 135,979 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-20 | 2016-01-21 | 2,114 | $69.40 | $146.7K | 138,045 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-20 | 2016-01-21 | 2,700 | $67.39 | $182.0K | 144,565 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-20 | 2016-01-21 | 4,406 | $68.35 | $301.2K | 140,159 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2016-01-19 | 2016-01-21 | 15,076 | — | $0 | 105,529 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-19 | 2016-01-21 | 200 | $78.04 | $15.6K | 133,389 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-19 | 2016-01-21 | 200 | $76.95 | $15.4K | 133,589 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-19 | 2016-01-21 | 2,245 | $75.97 | $170.6K | 133,789 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-19 | 2016-01-21 | 3,400 | $75.01 | $255.0K | 136,034 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-19 | 2016-01-21 | 5,112 | $74.14 | $379.0K | 139,434 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-19 | 2016-01-21 | 1,281 | $73.03 | $93.6K | 144,546 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-19 | 2016-01-21 | 800 | $71.81 | $57.4K | 145,827 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2016-01-19 | 2016-01-21 | 1,838 | $70.95 | $130.4K | 146,627 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2016-01-19 | 2016-01-21 | 15,076 | $22.75 | $343.0K | 148,465 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-12-18 | 2015-12-22 | 65,000 | — | $0 | 65,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-12-02 | 2015-12-04 | 58,689 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-12-02 | 2015-12-04 | 20,238 | $105.16 | $2.13M | 151,073 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-12-02 | 2015-12-04 | 10,784 | $104.00 | $1.12M | 171,311 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-12-02 | 2015-12-04 | 700 | $106.60 | $74.6K | 133,389 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-12-02 | 2015-12-04 | 58,689 | $13.12 | $770.0K | 192,078 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-12-02 | 2015-12-04 | 16,984 | $106.02 | $1.80M | 134,089 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-12-02 | 2015-12-04 | 9,983 | $103.15 | $1.03M | 182,095 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-11-20 | 2015-11-20 | 10,564 | — | $0 | 139,436 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-11-20 | 2015-11-20 | 58,690 | — | $0 | 58,689 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-11-20 | 2015-11-20 | 27,137 | $102.34 | $2.78M | 164,942 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-11-20 | 2015-11-20 | 23,483 | $103.13 | $2.42M | 141,459 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-11-20 | 2015-11-20 | 8,070 | $103.97 | $839.0K | 133,389 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-11-20 | 2015-11-20 | 10,564 | $7.10 | $75.0K | 192,079 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-11-20 | 2015-11-20 | 58,690 | $13.12 | $770.0K | 181,515 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | A Award deriv | 2015-06-23 | 2015-06-25 | 10,625 | — | $0 | 33,125 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | G Gift | 2015-06-15 | 2015-06-17 | 410 | — | $0 | 49,764 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award deriv | 2015-06-04 | 2015-06-08 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-05-01 | 2015-05-05 | 75,000 | — | $0 | 75,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | G Gift | 2015-04-28 | 2015-04-30 | 515 | — | $0 | 50,174 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | P Buy | 2015-01-26 | 2015-01-28 | 10,000 | $95.00 | $950.0K | 122,825 | SEC↗ |
| BLUE bluebird bio, Inc. | P Buy | 2014-12-19 | 2014-12-22 | 2,352 | $85.00 | $199.9K | 5,293 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS INC | P Buy | 2014-12-16 | 2014-12-18 | 1,806 | $110.75 | $200.0K | 50,689 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-12-15 | 2014-12-16 | 8,205 | — | $0 | 139,060 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-12-15 | 2014-12-16 | 8,205 | $9.14 | $75.0K | 112,825 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2014-12-12 | 2014-12-16 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-09-18 | 2014-09-19 | 56,834 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-09-18 | 2014-09-19 | 56,834 | $7.47 | $424.5K | 161,454 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-09-18 | 2014-09-19 | 18,962 | $78.12 | $1.48M | 142,492 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-09-18 | 2014-09-19 | 37,872 | $79.23 | $3.00M | 104,620 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-09-17 | 2014-09-19 | 56,834 | — | $0 | 56,834 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-09-17 | 2014-09-19 | 3,400 | $74.74 | $254.1K | 158,054 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-09-17 | 2014-09-19 | 13,899 | $75.65 | $1.05M | 144,155 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-09-17 | 2014-09-19 | 23,286 | $76.54 | $1.78M | 120,869 | SEC↗ |